Frontiers | The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer - Wakae - 2020 - Cancer Medicine - Wiley Online Library
Epstein-Barr Virus LMP1-Mediated Oncogenicity | Journal of Virology
Viruses | Free Full-Text | NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1
Genes | Free Full-Text | Latent Membrane Protein 1 (LMP1) from Epstein–Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 | PLOS Pathogens
Comparison of Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among four histological types of nasopharyngeal carcinoma | Chinese Medical Journal
The Epstein–Barr virus LMP1 interactome: biological implications and therapeutic targets | Future Virology
Viruses | Free Full-Text | NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1
Frontiers | Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity
Working model for LMP1 in EBV pathogenesis in a developing... | Download Scientific Diagram
Latent Membrane Protein 1 (LMP1) acts as a viral mimic of the... | Download Scientific Diagram
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy
Mouse model of Epstein–Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease | PNAS
Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma - Yoshizaki - 2018 - Cancer Science - Wiley Online Library
Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility | Genome Medicine | Full Text
Epstein–Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ | PNAS
Frontiers | EBV-associated diseases: Current therapeutics and emerging technologies
Latent Membrane Protein 1 - an overview | ScienceDirect Topics
Epstein–Barr virus‐mediated B‐cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor | The EMBO Journal
Epstein-Barr Virus LMP1-Mediated Oncogenicity | Journal of Virology
The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB | PNAS
Latent Membrane Protein 1 Promotes Tumorigenesis Through Upregulation of PGC1β Signaling Pathway | SpringerLink
Comparison of Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among four histological types of nasopharyngeal carcinoma | Chinese Medical Journal
Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells | Scientific Reports
